1. Trusting the Results of Model-Based Economic Analyses: Is there a Pragmatic Validation Solution?

   • Salah Ghabri
   • Matt Stevenson
   • J. Jaime Caro

   Current Opinion 06 September 2018 Pages: 1 - 6

2. Ibrutinib for Treating Waldenström’s Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

   • Paul Tappenden
   • Christopher Carroll
   • Rebecca Auer

   Review Article 27 June 2018 Pages: 7 - 18

   

3. Pembrolizumab for Previously Treated Advanced or Metastatic Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

   • Daniel Gallacher
   • Xavier Armoiry
   • Hema Mistry

   Review Article 21 July 2018 Pages: 19 - 27

4. One Method, Many Methodological Choices: A Structured Review of Discrete-Choice Experiments for Health State Valuation

   • Brendan Mulhern
   • Richard Norman
   • Rosalie Viney

   Systematic Review 08 September 2018 Pages: 29 - 43

   

5. Systematic Literature Review of the Economic Burden of Celiac Disease

   • Elizabeth S. Mearns
   • Aliki Taylor
   • Benjamin Lebwohl

   Systematic Review 17 September 2018 Pages: 45 - 61

   

6. Exploring Different Strategies of Assessing the Economic Impact of Multiple Diabetes-Associated Complications and Their Interactions: A Large Claims-Based Study in Germany

   • Katharina Kähm
   • Michael Laxy
   • Rolf Holle

   Original Research Article 30 August 2018 Pages: 63 - 74

   

7. The Impact of Moving from EQ-5D-3L to -5L in NICE Technology Appraisals

   • Becky Pennington
   • Monica Hernandez-Alava
   • Allan Wailoo

   Original Research Article 09 August 2018 Pages: 75 - 84

   

8. Health State Utilities for Acute Myeloid Leukaemia: A Time Trade-off Study

   • Namita Joshi
   • Marja Hensen
   • Elly Stolk

   Original Research Article 23 August 2018 Pages: 85 - 92

9. Estimating Informal Caregiving Time from Patient EQ-5D Data: The Informal CARE Effect (iCARE) Tool

   • Maria Gheorghe
   • Renske J. Hoefman
   • Job van Exel

   Original Research Article Open access 28 August 2018 Pages: 93 - 103

   

10. Q-TWiST Analysis to Assess Benefit–Risk of Pembrolizumab in Patients with PD-L1–Positive Advanced or Metastatic Non-small Cell Lung Cancer

    • Min Huang
    • M. Catherine Pietanza
    • A. Simon Pickard

    Original Research Article Open access 04 December 2018 Pages: 105 - 116

    

11. Correction to: The Future of Precision Medicine: Potential Impacts for Health Technology Assessment

    • James Love-Koh
    • Alison Peel
    • Matthew Taylor

    Correction 26 October 2018 Pages: 117 - 117